Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia

References

• Hug V, Keating M, McCredie K, et al. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer. 1983;52:773–779.
   PubMed Web of Science ®Google Scholar
• Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma. 2001;42:67–73.
   PubMed Web of Science ®Google Scholar
• Marbello L, Ricci F, Nosari AM, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res. 2008;32:1221–1227.
   PubMed Web of Science ®Google Scholar
• Oliveira LCO, Romano LGM, Prado-Junior BPA, et al. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol. 2010;27:1254–1259.
   PubMed Web of Science ®Google Scholar
• Oberoi S, Lehrnbecher T, Phillips B, et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res. 2014;38:460–468.
   PubMed Web of Science ®Google Scholar
• Greenwood MJ, Seftel MD, Richardson C, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma. 2006;47:1245–1252.
   PubMed Web of Science ®Google Scholar
• Novotny JR, Müller-Beissenhirtz H, Herget-Rosenthal S, et al. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol. 2005;74:501–510.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Lorenzo I, Martín G, et al. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008;93:67–74.
   PubMed Web of Science ®Google Scholar
• Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost. 2001;27:593–604.
   PubMed Web of Science ®Google Scholar
• Dechartres A, Chevret S, Lambert J, et al. Inclusion of patients with acute leukemia in clinical trials: a prospective multicenter survey of 1066 cases. Ann Oncol. 2011;22:224–233.
   PubMed Web of Science ®Google Scholar
• Porcu P, Danielson CF, Orazi A, et al. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol. 1997;98:433–436.
   PubMed Web of Science ®Google Scholar
• Chang M-C, Chen T-Y, Tang J-L, et al. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol. 2007;82:976–980.
   PubMed Web of Science ®Google Scholar
• Abla O, Khanani MF, Hitzler JK, et al. Complications of hyperleukocytosis and leukapheresis in pediatric acute leukemias [abstract]. Blood. 2004;104:1963.
   Google Scholar
• Lengliné E, Raffoux E, Lemiale V, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma. 2012;53:1352–1359.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Canet E, Raffoux E, et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J Off J. 2012;39:648–653.
   PubMed Web of Science ®Google Scholar
• Cokic VP, Beleslin-Cokic BB, Tomic M, et al. Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood. 2006;108:184–191.
   PubMed Web of Science ®Google Scholar
• Benkerrou M, Delarche C, Brahimi L, et al. Hydroxyurea corrects the dysregulated l-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood. 2002;99:2297–2303.
   PubMed Web of Science ®Google Scholar
• Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med. 1977;137:1246–1247.
   PubMed Web of Science ®Google Scholar
• Berg J, Vincent PC, Gunz FW. Extreme leucocytosis and prognosis of newly diagnosed patients with acute non-lymphocytic leukaemia. Med J Aust. 1979;1:480–482.
   PubMed Web of Science ®Google Scholar
• Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–474.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Altman A, Pui C-H, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26:2767–2778.
   PubMed Web of Science ®Google Scholar
• Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24–33.
   PubMed Web of Science ®Google Scholar
• Röllig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia? Blood. 2015;125:3246–3252.
   PubMed Web of Science ®Google Scholar
• Thiébaut A, Thomas X, Belhabri A, et al. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol. 2000;79:501–506.
   PubMed Web of Science ®Google Scholar
• Bug G, Anargyrou K, Tonn T, et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion (Paris). 2007;47:1843–1850.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood. 2009;113:28–36.
   PubMed Web of Science ®Google Scholar
• Bertoli S, Bérard E, Huguet F, et al. Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia. Blood. 2013;121:2618–2626.
   PubMed Web of Science ®Google Scholar
• Tryka AF, Godleski JJ, Fanta CH. Leukemic cell lysis pneumonopathy. A complication of treated myeloblastic leukemia. Cancer. 1982;50:2763–2770.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Fieux F, Moreau D, et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med. 2003;167:1329–1333.
   PubMed Web of Science ®Google Scholar
• Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer. 1992;69:1356–1361.
   PubMed Web of Science ®Google Scholar
• Lam WA, Rosenbluth MJ, Fletcher DA. Chemotherapy exposure increases leukemia cell stiffness. Blood. 2007;109:3505–3508.
   PubMed Web of Science ®Google Scholar
• Estey E, Smith TL, Keating MJ,et al. Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia. 1989;3:257–263.
   PubMed Web of Science ®Google Scholar
• de Jonge HJM, Valk PJM, de Bont ESJM, et al. Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD. Haematologica. 2011;96:1310–1317.
   PubMed Web of Science ®Google Scholar
• Mokart D, Pastores SM, Darmon M. Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med. 2014;40:1570–1572.
   PubMed Web of Science ®Google Scholar
• Pène F, Salluh JIF, Staudinger T. Has survival increased in cancer patients admitted to the ICU? No. Intensive Care Med. 2014;40:1573–1575.
   PubMed Web of Science ®Google Scholar
• van Vliet M, Verburg IWM, van den Boogaard M, et al. Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med. 2014;40:1275–1284.
   PubMed Web of Science ®Google Scholar
• Othus M, Kantarjian H, Petersdorf S, et al. Declining rates of treatment-related mortality in patients with newly diagnosed AML given “intense” induction regimens: a report from SWOG and MD Anderson. Leukemia. 2014;28:289–292.
   PubMed Web of Science ®Google Scholar
• Percival M-EM, Tao L, Medeiros BC, et al. Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: a SEER database analysis. Cancer. 2015;121:2004–2012.
   PubMed Web of Science ®Google Scholar